• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SD filed by Outset Medical Inc.

    5/29/25 4:05:14 PM ET
    $OM
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $OM alert in real time by email
    SD 1 om_sd_2025.htm SD SD

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM SD

     

    Specialized Disclosure Report

     

     

    Outset Medical, Inc.

    (Exact name of the registrant as specified in its charter)

     

     

    Delaware

    001-39513

    20-0514392

    (State or other jurisdiction of incorporation)

    (Commission file number)

    (I.R.S. Employer Identification No.)

     

    3052 Orchard Drive, San Jose, California

    95134

    (Address of principal executive offices)

    (Zip Code)

     

    Leslie Trigg

    (669) 231-8200

    (Name and telephone number, including area code, of the person to contact in connection with this report.)

     

     

    Check the appropriate box to indicate the rule pursuant to which this form is being filed:

     

    ☒

    Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1, 2024 to December 31, 2024.

    ☐

    Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended________.

     


    Section 1 – Conflict Minerals Disclosure

     

    Item 1.01 Conflict Minerals Disclosure and Report

    This Specialized Disclosure Report on Form SD (the “Form SD”) of Outset Medical, Inc. (“Outset”) is filed pursuant to Rule 13p-1 promulgated under the Securities Exchange Act of 1934, as amended, for the reporting period January 1, 2024 to December 31, 2024.

     

    A copy of Outset’s Conflict Minerals Report is filed as Exhibit 1.01 and incorporated herein by reference, and is publicly available on Outset’s website at https://investors.outsetmedical.com/financial-information/sec-filings. Information posted on or accessible through this website is not incorporated by reference nor otherwise included in this report, and any references to this website are intended to be inactive textual references only.

     

    Item 1.02 Exhibit

     

    As specified in Section 2, Item 2.01 of this Form SD, Outset is hereby filing its Conflict Minerals Report as Exhibit 1.01 to this report.

     

    Section 2 – Resource Extraction Issuer Disclosure

     

    Item 2.01 Resource Extraction Issuer Disclosure and Report

     

    Not applicable.

     

    Section 3 – Exhibits

     

    Item 3.01 Exhibits

     

    The following exhibit is filed as part of this report.

     

    Exhibit Number

     

    Description

    1.01

     

    Conflict Minerals Report of Outset Medical, Inc. for the reporting period from January 1, 2024 to December 31, 2024

     

     

     

     


    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

     

    Outset Medical, Inc.

     

     

    (Registrant)

     

     

     

     

     

    By: /s/ John Brottem

     

    May 29, 2025

    John Brottem

    General Counsel

     

    (Date)

     


    Get the next $OM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $OM

    DatePrice TargetRatingAnalyst
    8/8/2024$6.00 → $3.00Outperform → Sector Perform
    RBC Capital Mkts
    6/21/2024$5.00 → $6.00Sector Perform → Outperform
    RBC Capital Mkts
    4/8/2024$6.00Buy
    BTIG Research
    4/5/2024$6.00Neutral → Buy
    CL King
    1/12/2024$14.00 → $6.00Outperform → Sector Perform
    RBC Capital Mkts
    10/13/2023$32.00 → $3.00Buy → Underperform
    BofA Securities
    8/17/2023Neutral
    CL King
    11/11/2022$23.00Outperform
    RBC Capital Mkts
    More analyst ratings